Metoprolol retard antihypertensive effectiveness in patients with mild to moderate arterial hypertension (multi-center study "Prolonger" results)
About the Authors
Yu. N. SirenkoRussian Federation
O. L. Rekovets
Russian Federation
G. V. Dzyak
Russian Federation
A. E. Bagriy
Russian Federation
S. N. Polivoda
Russian Federation
V. A. Vizir
Russian Federation
S. A. Andrievskaya
Russian Federation
A. A. Andrievskaya
Russian Federation
A. A. Cherepok
Russian Federation
O. A. Prikolota
Russian Federation
A. E. Berezin
Russian Federation
O. V. Govorova
Russian Federation
References
1. Dahlof В., Hansson L., Lindholm L.H., et al. Swedish trial in old patients with hypertension (STOP-Hypertension): analyses performed up to 1992//Clin. Exp. Hypertension. 1993. Vol. 15. P. 925-939.
2. Dahlof В., Lindholm L.H., Hansson L. etal. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)//Lancet. 1991. Vol. 338. R 1281-1285.
3. Genth-Zotz S., Zotz R., Sigmund M., et al. MIC Trial: Metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing//Eur. J. Heart Failure. 2000. Vol. 2. P. 175-181.
4. Hansson L., Dahlof В., Ekbom T., et al. Key learnings from the STOP Hypertension study: an update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly//Cardiovasc. Drug Ther. 1990. Vol. 4. P. 1253-1256.
5. Hansson L., Hedner T. Hypertension Manual 2000. Falkoping: Layout Bohlin Production AB, 2000. 128 p.
6. Hypertension Primer. The essentials of high blood pressure//The council on high blood pressure research American Heart Association. N.Y.: AHA, 1999. 471 p.
7. Johannesson M., Dahlof В., Lindholm L.H., et al. The cost-effec tiveness of treating hypertension in elderly people -an analysis of the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)//J. Intern. Med. 1993. Vol. 234. P. 317-323.
8. Kjekshus J.K. According to MIAMI and ISIS-1 trials, can a general recommendation be given for beta-blockers in acute myocardial infarction?//Cardiovasc. Drugs Ther. 1988. Vol. 2. P. 113-119.
9. LaPalio L., Schork A., Glasser S., et al. Safety and efficacy of metoprolol in treatment of hypertension in the elderly // J. Amer. Geriatr. SoC. 1992. Vol. 40. P. 354-358.
10. Luomanmaki K., Inkovaara J., Hartikainen M., et al. Efficacy and tolerability of isradipine and metoprolol in treatment of hypertension: the Finnish Isradipine Study in Hypertension (FISH)//J. Cardiovasc. Pharmacology. 1992. Vol. 20. P. 296-303.
11. White W. Blood pressure monitoring in cardiovascular medicine and therapeutics. New Jersey: Humana Press, 2001. 308 p.
12. 1999 WHO -ISH guidelines for the management of hypertension//J. Hypertension. 1999. Vol. 11. P. 905-916.
Review
For citations:
Sirenko Yu.N., Rekovets O.L., Dzyak G.V., Bagriy A.E., Polivoda S.N., Vizir V.A., Andrievskaya S.A., Andrievskaya A.A., Cherepok A.A., Prikolota O.A., Berezin A.E., Govorova O.V. Metoprolol retard antihypertensive effectiveness in patients with mild to moderate arterial hypertension (multi-center study "Prolonger" results). Russian Journal of Cardiology. 2006;(2):67-72. (In Russ.)